THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (80K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 7/7/2022ACC: 0001493152-22-018805
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-80K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
7/5/2022
202.14M→202.12M
Common Stock
Direct
Shares
−60K
Price / share
—
Trade value
—
% of position
0.0%
7/6/2022
202.12M→202.06M
Total
Net shares
−80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/5/2022 | S · Sale | −20K | — | — | 0.0% | 202.14M | 202.12M |
| Common Stock Direct | 7/6/2022 | S · Sale | −60K | — | — | 0.0% | 202.12M | 202.06M |
| Total | −80K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported